# CSF Protein Markers as Prognostic Indicators of the Response to CSF Shunt in Normotensive Hydrocephalus

> **NCT05915000** · — · RECRUITING · sponsor: **University of Valencia** · enrollment: 150 (estimated)

## Conditions studied

- Beta-amiloid and Phospho-tau Proteins in CSF
- Ventricular Size After CSF Shunt
- Cognitive Impairment and CSF Shunt
- Motor Impairment Evolution After CSF Shunt

## Interventions

- **DIAGNOSTIC_TEST:** Lumbar CSF protein marker determination

## Key facts

- **NCT ID:** NCT05915000
- **Lead sponsor:** University of Valencia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-06-13
- **Primary completion:** 2029-03-17
- **Final completion:** 2029-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05915000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05915000, "CSF Protein Markers as Prognostic Indicators of the Response to CSF Shunt in Normotensive Hydrocephalus". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05915000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*